Loss-of-function of the INK4-cyclin D/CDK4/6-RB pathway is a common event in variety of cancers including breast cancer 42 and p18 expression is significantly lower in human luminal breast cancers 8, consistent with our finding that loss of p18 in mice induces luminal mammary tumors 27. Here, CDKN2A is linked to breast carcinoma.